Anteris Technologies Global Corp. (NASDAQ:AVR – Get Free Report) major shareholder L1 Capital Pty Ltd sold 155,505 shares of the stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $8.04, for a total value of $1,250,260.20. Following the sale, the insider owned 7,191,947 shares in the company, valued at $57,823,253.88. The trade was a 2.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
L1 Capital Pty Ltd also recently made the following trade(s):
- On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.20, for a total transaction of $4,580,790.60.
- On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.19, for a total value of $1,906,771.23.
- On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.09, for a total value of $1,688,633.79.
- On Friday, July 24th, L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.13, for a total value of $186,990.00.
Anteris Technologies Global Price Performance
Shares of AVR opened at $7.84 on Friday. The company’s fifty day moving average price is $9.22 and its 200-day moving average price is $7.14. The firm has a market capitalization of $763.15 million, a PE ratio of -3.52 and a beta of 1.65. Anteris Technologies Global Corp. has a 1-year low of $2.99 and a 1-year high of $11.06.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Friday, May 29th. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Finally, Barclays raised their target price on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Anteris Technologies Global has an average rating of “Moderate Buy” and an average target price of $16.00.
Get Our Latest Stock Report on Anteris Technologies Global
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the business. L1 Capital Pty Ltd boosted its holdings in Anteris Technologies Global by 143.2% in the third quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after acquiring an additional 4,026,136 shares during the last quarter. ADAR1 Capital Management LLC grew its holdings in Anteris Technologies Global by 205.9% during the 1st quarter. ADAR1 Capital Management LLC now owns 3,789,132 shares of the company’s stock worth $21,030,000 after acquiring an additional 2,550,355 shares in the last quarter. Perceptive Advisors LLC grew its position in shares of Anteris Technologies Global by 104.4% in the 1st quarter. Perceptive Advisors LLC now owns 3,425,476 shares of the company’s stock worth $19,011,000 after acquiring an additional 1,750,000 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Anteris Technologies Global by 9,958.6% in the second quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock worth $4,049,000 after purchasing an additional 1,057,707 shares during the period. Finally, Militia Capital Management LLC bought a new stake in shares of Anteris Technologies Global during the 1st quarter valued at about $3,663,000.
Anteris Technologies Global Company Profile
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Read More
- Five stocks we like better than Anteris Technologies Global
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
